Online Enquiry
Subscribe
Log in / New User
Retrieve Password
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Log In
|
New User Registration
|
Retrieve Password
Log In
News
TheMarket
IndustryNews
RegulatoryNews
GeneralHealth
Legal/IPRNews
Product/R&DNews
API/BulkDrugNews
PeopleintheNews
OtherNews
TopNewsWorldwide
FEATURE ARTICLES
Editorials
Commentaries
ExpertOpinions
Interviews
CaseStudies
CompanyProfiles
Editor'sPicks
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
IQVIA: Chinese Hospital Drug Market Rose 4.2% in 2023 (MAT Q4/2023)
In the fourth quarter of 2023, Chinese hospital drug sales were up 2.2% qoq, while those in MAT Q4/2023 surged 4.2% compared with MAT Q4/2022, according to a recent topli...
(3/13/2024)
BIOSECURE Act May Implicate WuXi-Produced Drug... (3/27/2024)
U.S.-China Decoupling Poses Supply-Chain Risks... (3/27/2024)
China Plays Down Concerns Over State Health In... (3/26/2024)
Anti-China Bills Portend Massive Blow to Biote... (3/26/2024)
Chinese Biotechs See Cash Again; Late-stage As... (3/26/2024)
Chinese ADC Developers Unveil More Target Comb... (3/25/2024)
Lilly CEO Reaffirms Commitment to Chinese Mark... (3/25/2024)
China Ranked Top Potential Biopharma Outsourci... (3/20/2024)
Perspectives on 2024's Two Sessions (NCUSCR) (3/19/2024)
Genscript Losses Shrink on Strong Growth for C... (3/19/2024)
The US and Chinese Biopharma Contractors (Scie... (3/18/2024)
Major Life Sciences Licensing Deal Trends in C... (3/15/2024)
Mitsui & Rohto-led Consortium Near Deal ... (3/27/2024)
China's Primary Healthcare Institutions ... (3/27/2024)
Oncology Partnerships in China Account f... (3/27/2024)
NMPA Holds National Conference on Drug R... (3/27/2024)
NIFDC Issues the 2023 National Drug Samp... (3/27/2024)
AstraZeneca Plans to Divide Drug Product... (3/27/2024)
AZ and Pfizer CEOs Pledge Support for Ch... (3/26/2024)
Stemirna Therapeutics Faces Setback as C... (3/26/2024)
China's Basic Medical Insurance Scheme M... (3/26/2024)
AriBio Licenses Alzheimer's Pill in Chin... (3/26/2024)
NMPA Publishes the 2023 Annual Report fo... (3/26/2024)
Big Pharma CEOs Pledge Commitment at Chi... (3/26/2024)
Nuvation Bio to Acquire AnHeart Therapeu... (3/26/2024)
China Unveils Plans for Market Access an... (3/25/2024)
Recent Official and Executive Moves (3/22/2024)
Drug R&D and Product Registration News D... (3/22/2024)
NMPA Announces Package Insert Revision o... (3/22/2024)
CDE Solicits Comments on Draft Implement... (3/22/2024)
China Unveils Plans for Market Access and Data Regulati...
China Offers Huge Weight-loss Drug Market Potential for...
Sinohealth: Review of Chinese Retail Pharmacy Drug Sale...
PhIIC: Review of Prescription Drug Sales Trends in Chin...
IQVIA: Chinese Hospital Drug Market Rose 4.2% in 2023 (...
AstraZeneca Plans to Divide Drug Production between US ...
Oncology Partnerships in China Account for 41% of All D...
Mitsui & Rohto-led Consortium Near Deal to Acquire Eu Y...
Nuvation Bio to Acquire AnHeart Therapeutics in All-Sto...
Big Pharma CEOs Pledge Commitment at China Development ...
NIFDC Issues the 2023 National Drug Sample Inspection A...
NMPA Holds National Conference on Drug Registration and...
NMPA Publishes the 2023 Annual Report for Adverse Drug ...
China Eases Cross-Border Data Transfer Rules to Allevia...
CDE Solicits Comments on Draft Implementation Suggestio...
China's Primary Healthcare Institutions Handle Over Hal...
China's Basic Medical Insurance Scheme Maintains Stable...
NHC Unveils Ambitious Plan to Elevate Healthcare System
China to Expand Pilot Program for Medical Services Pric...
China Issues New Document on Advancing Physician Electr...
CDE Introduces a Legal Document Submission Module on th...
Narrowly Tailored U.S. Bill Targeting Chinese Biotech C...
Baricitinib's Patent Woes in China: CNIPA Invalidates O...
CNIPA to Allow Third-Party Challenges to Pharmaceutical...
State Council Issues Amended Implementing Regulations o...
India Mulls New PLI Scheme to Reduce Chinese API Depend...
FDA Criticizes Chinese API Producer for Deceptive Pract...
US Urges Indian Pharma to Distance from China for APIs ...
Chinese Researchers Makes Breakthrough with Paclitaxel ...
Crescent HiTech to Build New API Facility in Bangladesh...
Drug R&D and Product Registration News Digest March 202...
Drug R&D and Product Registration News Digest March 202...
Drug R&D and Product Registration News Digest March 202...
Drug R&D and Product Registration News Digest February ...
Chinese Pharma R&D Investment Grew by Nearly 20% in 202...
BioAtla and BeiGene Revise Global Deal for Novel Condit...
Pfizer to Absorb Mylan, Creating Global Generic Powerho...
PhRMA Calls for Trade Deals That Force Countries to Pay...
IQVIA: Global Pharma to Grow Slower in the Next Five Ye...
Pfizer and GSK Announce JV to Create a Global Consumer ...
Recent Official and Executive Moves
Recent Executive Moves
Recent Official Changes and Executive Moves
Recent Official Changes and Executive Moves
Recent Official and Executive Moves
China Introduces Plan for Pudong New Area's Pilot Compr...
Upcoming Event: 2023 Pharma CI USA Conference & Exhibit...
Upcoming Event: 15th Annual Pharma Market Research Conf...
Upcoming Event: 6th International Conference on Emergin...
Upcoming Event: PHARM Connect Congress
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
2023 Order Form + Product Descripti...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WEEKLY e-ALERT(Premium)
WEEKLY e-ALERT(Basic)
GENERAL INFORMATION
TERMS/CONDITIONS OF USE
PRIVACY STATEMENT
JOIN THE MAILING LIST
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit